2,0
8 mar 2016
Exempleado, más de 5 años
Recomendar
Aprobación del CEO
Perspectiva de la empresa
Ventajas
Novel technology, dedicated colleagues. Excellent customer base among the top Pharma companies around the world. Excellent benefits.
Desventajas
After the takeover by Accelrys, the future development of the SmartLab enterprise platform was abandoned, as well as many of the employees who helped build the ELN business.